Trialect

Active

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

National Institutes of Health

This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 – 10 years.

Deadlines:

Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date(s): May 26, 2022; Sep 26, 2022; May 26, 2023; Sep 26, 2023; May 24, 2024; Sep 26, 2024
AIDS Application Due Dates: Sep 7, 2022; Jan 9, 2023; Sep 7, 2023; Jan 8, 2024; Sep 6, 2024; Jan 7, 2025

PAR-22-123 Expiration Date January 08, 2025

Specialties

Engineering and Physical Sciences

Interdisciplinary

Medical - Basic Science

Medical - Translational

Environmental & Life Sciences

Medical

Medical - Clinical Science

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

View Funding Opportunity

Grant

Final Deadline:

Sep 26, 2024

LOI Deadline: 30 days prior to the application due date Application Due Date(s): May 26, 2022; Sep 26, 2022; May 26, 2023; Sep 26, 2023; May 24, 2024; Sep 26, 2024